Ruta Petraitiene Selected Research

Biomarkers (Surrogate Marker)

12/2022	Osteoarticular Mycoses.
9/2020	Modeling Invasive Aspergillosis: How Close Are Predicted Antifungal Targets?
5/2017	Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.
9/2016	(1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.
8/2015	Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.
5/2015	Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus.
6/2014	Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic response.
1/2013	Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.
11/2010	The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.
11/2008	Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruta Petraitiene Research Topics

Disease

22	Invasive Pulmonary Aspergillosis 01/2021 - 01/2002
19	Infections 04/2024 - 07/2003
14	Body Weight (Weight, Body) 10/2021 - 01/2002
12	Aspergillosis 09/2020 - 01/2002
9	Lung Injury 10/2022 - 01/2002
7	Candidiasis (Moniliasis) 11/2017 - 06/2002
7	Pulmonary Aspergillosis 09/2013 - 01/2002
6	Mycoses (Diseases, Fungus) 12/2022 - 12/2003
6	Meningoencephalitis 02/2021 - 01/2008
5	Pneumonia (Pneumonitis) 10/2022 - 12/2010
4	Infarction (Infarctions) 09/2020 - 06/2009
4	Pulmonary Infarction 01/2016 - 01/2002
3	Invasive Candidiasis 11/2017 - 01/2006
2	Bacterial Pneumonia 04/2024 - 01/2009
2	Candidemia 04/2024 - 01/2021
2	Arthritis (Polyarthritis) 12/2022 - 01/2016
2	Bacteremia 10/2021 - 01/2020
2	Phaeohyphomycosis 02/2021 - 03/2020
2	Neutropenia 03/2020 - 08/2015
2	Mucormycosis 12/2018 - 01/2013
2	Invasive Fungal Infections 05/2017 - 01/2017
2	Chronic Granulomatous Disease 01/2011 - 02/2006
1	Gram-Negative Bacterial Infections 04/2024
1	Infectious Arthritis (Septic Arthritis) 12/2022
1	Osteomyelitis 12/2022
1	Chronic Disease (Chronic Diseases) 10/2021
1	Endophthalmitis (Ophthalmia) 01/2021
1	Germinoma 01/2017
1	Fungal Lung Diseases 11/2014
1	Fungal Meningitis 03/2013
1	Burkholderia Infections 01/2011
1	Bacterial Infections (Bacterial Infection) 01/2011
1	Inflammation (Inflammations) 01/2011

Drug/Important Bio-Agent (IBA)

15	Amphotericin B (Amphotericin)FDA LinkGeneric 09/2020 - 01/2002
13	Biomarkers (Surrogate Marker)IBA 12/2022 - 02/2006
13	galactomannanIBA 01/2021 - 01/2002
10	Micafungin (FK463)FDA Link 04/2024 - 06/2002
9	isavuconazoleIBA 02/2021 - 11/2014
8	TriazolesIBA 02/2021 - 06/2003
7	liposomal amphotericin B FDA Link 02/2021 - 06/2002
7	EchinocandinsIBA 11/2017 - 01/2002
6	EnzymesIBA 01/2011 - 10/2004
4	Deoxycholic Acid (Sodium Deoxycholate)IBA 09/2020 - 01/2002
3	posaconazole FDA Link 01/2021 - 03/2020
3	Anidulafungin FDA Link 09/2020 - 06/2009
3	Voriconazole (Vfend)FDA LinkGeneric 09/2020 - 06/2009
3	Caspofungin (Cancidas)FDA Link 09/2020 - 01/2002
3	Methylprednisolone FDA LinkGeneric 03/2020 - 03/2013
3	deoxycholate drug combination amphotericin BIBA 05/2015 - 10/2006
3	AntigensIBA 09/2008 - 01/2002
3	ER 30346 (ravuconazole)IBA 10/2006 - 06/2003
2	Anti-Infective Agents (Microbicides)IBA 04/2024 - 10/2021
2	ceftazidime drug combination avibactamIBA 01/2022 - 01/2020
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 10/2021 - 10/2004
2	ProdrugsIBA 01/2021 - 01/2016
2	ibrexafungerpIBA 09/2020 - 01/2020
2	Antifungal AgentsIBA 09/2020 - 01/2017
2	PolyenesIBA 11/2017 - 12/2003
2	Nucleic AcidsIBA 01/2017 - 11/2014
2	HaptoglobinsIBA 06/2014 - 12/2010
2	Proteins (Proteins, Gene)FDA Link 06/2014 - 12/2010
2	C-Reactive ProteinIBA 06/2014 - 12/2010
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2011 - 02/2006
2	polyglucosanIBA 11/2010 - 11/2008
2	Dihydrotachysterol (AT 10)IBA 06/2009 - 05/2005
2	2- amino- 4- methylenecyclopentane- 1- carboxylic acidIBA 05/2005 - 10/2004
2	Fluconazole (Zonal)FDA LinkGeneric 05/2005 - 10/2004
2	Isoleucine-tRNA LigaseIBA 05/2005 - 10/2004
1	Carbapenems (Carbapenem Antibiotics)IBA 04/2024
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2022
1	CefiderocolIBA 10/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022
1	Aztreonam FDA LinkGeneric 01/2022
1	Vancomycin FDA LinkGeneric 10/2021
1	Meropenem (Merrem)FDA LinkGeneric 10/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2020
1	TriterpenesIBA 01/2020
1	carbapenemaseIBA 01/2020
1	PorinsIBA 01/2019
1	tazobactam drug combination ceftolozaneIBA 01/2019
1	eravacyclineIBA 01/2018
1	CarbohydratesIBA 05/2017
1	VaccinesIBA 01/2017
1	LipopeptidesIBA 12/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2015
1	Annexin A1IBA 06/2014
1	AgarIBA 09/2013
1	Glucose (Dextrose)FDA LinkGeneric 09/2013
1	trypticase-soy broth (trypticase soy)IBA 09/2013
1	Oxidants (Oxidizing Agents)IBA 01/2011
1	Serine Proteases (Serine Protease)IBA 01/2011
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2011

Therapy/Procedure

27	Therapeutics 04/2024 - 01/2002
2	Vascular Access Devices (Arterial Line) 04/2024 - 10/2021
2	Drug Therapy (Chemotherapy) 01/2017 - 02/2007
1	Mechanical Ventilators (Ventilator) 04/2024
1	Central Venous Catheters 04/2024
1	Catheters 04/2024
1	Duration of Therapy 12/2022
1	Intravenous Infusions 01/2020